Coronavirus Infection

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

Outcomes in Critically Ill Patients With COVID-19

Active, not recruiting
  • Coronavirus Infection
  • No intervention
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 16, 2022

Coronavirus Infection Trial in Worldwide (Hydroxychloroquine SAR321068, Placebo)

Terminated
  • Coronavirus Infection
  • Hydroxychloroquine SAR321068
  • Placebo
  • Boston, Massachusetts
  • +6 more
Apr 21, 2022

Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United

Recruiting
  • Coronavirus Infection
  • +2 more
  • Drug: NA-831
  • +3 more
  • Los Angeles, California
  • +30 more
Jan 31, 2022

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
  • Coronavirus Infection
  • Los Angeles, California
  • +32 more
Oct 27, 2021